BioRestorative Short Term Debt from 2010 to 2024

BRTX Stock  USD 1.53  0.05  3.38%   
BioRestorative Therapies Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt will likely drop to about 154.2 K in 2024. During the period from 2010 to 2024, BioRestorative Therapies Short Term Debt regression line of annual values had r-squared of  0.09 and arithmetic mean of  2,239,812. View All Fundamentals
 
Short Term Debt  
First Reported
2010-12-31
Previous Quarter
167.2 K
Current Value
42.4 K
Quarterly Volatility
2.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.4 M or Depreciation And Amortization of 177.8 K, as well as many indicators such as Price To Sales Ratio of 47.82, Dividend Yield of 0.0 or PTB Ratio of 0.77. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.
  
Check out the analysis of BioRestorative Therapies Correlation against competitors.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Latest BioRestorative Therapies' Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of BioRestorative Therapies over the last few years. It is BioRestorative Therapies' Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Slightly volatile
   Short Term Debt   
       Timeline  

BioRestorative Short Term Debt Regression Statistics

Arithmetic Mean2,239,812
Geometric Mean1,109,913
Coefficient Of Variation103.13
Mean Deviation1,947,325
Median1,009,797
Standard Deviation2,309,838
Sample Variance5.3T
Range7.1M
R-Value(0.30)
Mean Square Error5.2T
R-Squared0.09
Significance0.27
Slope(156,722)
Total Sum of Squares74.7T

BioRestorative Short Term Debt History

2024154.2 K
2023162.3 K
2022278.7 K
2021297.1 K
2020316.7 K
20197.2 M
20183.6 M

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt162.3 K154.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.